All trials - page: 200

All trials

Displaying of results
Download as CSV
NCTID
Brief title
Sponsor
Design
Criteria
Status
Target enrollment
Study phase & design
Primary intervention type
Primary potential benefit
Outcome measure
Follow up
Start date
First posted
Location
NCT02363361Treatment of Cervical Spinal Cord Injury With Imatinib - a Safety and Feasibility StudyKarolinska University Hospital
  • Age 18 - 80 yrs
  • Level C1-S5
  • AIS A, B, C, D
  • ≤ 80 years
10PHASE2DrugGeneral health01 April 201816 February 20150
NCT02602639Functional Electrical Stimulation With Rowing as Exercise After Spinal Cord InjuryUniversity of Manitoba
  • Age 18 - 75 yrs
  • Level C5-T12
  • AIS A, B, C, D
  • ≤ 75 years
6NARehabilitationGeneral health01 October 201511 November 20151
NCT02604927Beta-alanine Supplementation and Its Effects on Performance, Muscle Carnosine Content and Safety in Athletes With Spinal-cord InjuryUniversity of Sao Paulo
  • Age 18 - 40 yrs
  • Level C1-S5
  • AIS A, B, C, D
  • 1 years - 40 years
20NAArm/hand function01 February 201616 November 20151
NCT02672670Effects of a Coping-oriented Supportive Programme (COSP) for People With Spinal Cord Injury During Inpatient RehabilitationThe Hong Kong Polytechnic University
  • Age 18 - 64 yrs
  • Level C1-S5
  • AIS A, B, C, D
  • ≤ 2 years
100NAMental health and psychosocial factors01 August 201603 February 20161
NCT02721615Injured Spinal Cord Pressure EvaluationSt George's, University of London
  • Age 18 - 70 yrs
  • Level C1-S5
  • AIS A, B, C
  • ≤ 72 hours
100NASurgeryGeneral health01 September 201029 March 20161
NCT03503513Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord InjuryUniversity of Michigan
  • Age 18 - 80 yrs
  • Level C1-S5
  • AIS A, B, C, D
  • 6 months - 80 years
Ended23PHASE2, PHASE3DrugBladder health/function24 August 201819 April 20181